| Laura Whiteside, | |
|
140 E Rawson Ave Ste 317, Oak Creek, WI 53154-1525 | |
| (262) 287-0090 | |
| Not Available |
| Full Name | Laura Whiteside |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 140 E Rawson Ave Ste 317, Oak Creek, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023755576 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura Whiteside, 3909 N Murray Ave Apt 306, Milwaukee, WI 53211-2307 Ph: () - | Laura Whiteside, 140 E Rawson Ave Ste 317, Oak Creek, WI 53154-1525 Ph: (262) 287-0090 |
News Archive
These Republican officials argue that as federal funding for Medicaid has expanded, so has federal control. Their argument to include the measure in debt-ceiling legislation is raising concern among some Medicaid advocates.
A transgender man in his 30's was able to carry a child after taking female hormones to reverse the effects of his female-to-male sex change treatment. The man from the West Midlands, UK is in a long-term relationship. It is not clear whether his partner is male or female. Medical ethics experts have called for a full inquiry into the issues surrounding transgender births, saying the interests of the child should not be risked to "fulfill the rights of an adult".
When you need medical care, it can be a lot like entering a casino — playing for your financial life with the deck stacked against you.
The New England Journal of Medicine (NEJM) published a study today that shows Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival (PFS), or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET).
Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication for Bayer's Kogenate® FS antihemophilic factor VIII (recombinant), for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.
› Verified 8 days ago
Michelle Kondrat, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 E Rawson Ave Ste 317, Oak Creek, WI 53154 Phone: 262-287-0090 | |
Nicole Marie Mcgillicuddy, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2700 W Honadel Blvd, Oak Creek, WI 53154 Phone: 414-435-2005 | |
Rachelle Verhulst, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 E Rawson Ave, Ste 317, Oak Creek, WI 53154 Phone: 262-287-0090 | |
Chloe Elizabeth Nolan Shoup, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 E Rawson Ave Ste 317, Oak Creek, WI 53154 Phone: 262-287-0090 | |
Jenna Nicole Cooper, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 E Ryan Rd, Oak Creek, WI 53154 Phone: 414-570-3590 | |
Robin K Hecox, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 E Rawson Ave Ste 317, Oak Creek, WI 53154 Phone: 262-287-0090 |